Blog
RSS FeedPosted by Michael Wonder on 01 Dec 2020
US hopeful of pre-Christmas COVID jab, Australia still has long wait
1 December 2020 - Millions of vulnerable Americans could be vaccinated against coronavirus before the end of 2020 but it ...
Posted by Michael Wonder on 23 Nov 2020
COVID-19 shots could reach first Americans by mid-December, top health official says
23 November 2020 - U.S. health care workers and others recommended for the nation’s first COVID-19 inoculations could start getting shots ...
Posted by Michael Wonder on 23 Nov 2020
Theralase granted FDA fast track designation for NMIBC Phase 2 clinical study
23 November 2020 - Theralase Technologies announced today that the U.S. FDA has granted Theralase fast track designation for its ...
Posted by Michael Wonder on 23 Nov 2020
AB201 development as a potential treatment for COVID-19 receives U.S. FDA fast track designation
23 November 2020 - AB201 is the only novel compound being developed for COVID associated coagulopathy. ...
Posted by Michael Wonder on 23 Nov 2020
Kiniksa announces U.S. FDA acceptance of sBLA and priority review for rilonacept in recurrent pericarditis
23 November 2020 - Filing based on positive data from RHAPSODY, which achieved its primary and all major secondary endpoints. ...
Posted by Michael Wonder on 23 Nov 2020
Catalent signs commercial supply agreement with Blueprint Medicines following FDA approval of Gavreto (pralsetinib)
23 November 2020 - Catalent today announced that it had entered into a commercial supply agreement with Blueprint Medicines following FDA ...
Posted by Michael Wonder on 23 Nov 2020
FDA expands approval of influenza treatment to post-exposure prevention
23 November 2020 - Today, the U.S. FDA expanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of ...
Posted by Michael Wonder on 23 Nov 2020
BeiGene announces the approval of Xgeva (denosumab) in China for the prevention of skeletal-related events in patients with bone metastases from solid tumours and in patients with multiple myeloma
19 November 2020 - BeiGene today announced that the China NMPA has approved Xgeva (denosumab) for the prevention of skeletal-related events ...
Posted by Michael Wonder on 23 Nov 2020
argenx enters into agreement to acquire priority review voucher
23 November 2020 - argenx today announced that the company has agreed to acquire a U.S. FDA priority review voucher from ...
Posted by Michael Wonder on 23 Nov 2020
European Commission approves MenQuadfi, the latest innovation in meningococcal vaccination for individuals 12 months of age and older
23 November 2020 - EC approval based on robust data from seven pivotal Phase 2 and 3 trials involving more than ...
Posted by Michael Wonder on 23 Nov 2020
Woman trying to raise $110,000 a month for life-extending breast cancer treatment
23 November 2020 - “Pay up or die” is the choice for a woman in her 30s trying to raise ...
Posted by Michael Wonder on 23 Nov 2020
Politics, science and the remarkable race for a coronavirus vaccine
21 November 2020 - The furious race to develop a coronavirus vaccine played out against a presidential election, between a pharmaceutical ...
Posted by Michael Wonder on 23 Nov 2020
Alexion receives marketing authorisation from European Commission for new formulation of Ultomiris (ravulizumab) with significantly reduced infusion time
20 November 2020 - The new 100 mg/mL formulation will reduce infusion time by approximately 60%, lessening the burden on patients. ...
Posted by Michael Wonder on 23 Nov 2020
Ethinyloestradiol 20 mcg with desogestrel 150 mcg and 7 inert tablets (Mercilon 28)
23 November 2020 - Ethinyloestradiol 20 mcg with desogestrel 150 mcg and 7 inert tablets (Mercilon 28) will be fully funded ...
Posted by Michael Wonder on 23 Nov 2020
Funding changes to dornase alfa for cystic fibrosis
23 November 2020 - From 1 December 2020 dornase alfa will be listed in the Community and the Hospital Medicines List ...
Posted by Michael Wonder on 22 Nov 2020
Stage 2 PBS process improvements and revised cost recovery arrangements - information forum
23 November 2020 - The Department of Health will host a webinar on 7 December 2020, to launch Stage 2 ...